Chronic Myeloid Leukemia (CML) is a malignant myeloproliferative disease driven by the presence of the BCR-ABL1 fusion product generated as a result of the t(9;22) Philadelphia chromosome (Ph). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.